Preclinical Efficacy Testing for Stomach and Liver Cancers

PURPOSE: Hollow fiber assays offer an early in vivo method of anticancer drug screening. The assays have been optimized for human cancers originating from the lung, breast, colon, ovary, and brain, but not from the stomach and liver. The current study focused on optimization of hollow fiber assays f...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun Won, Baek, Nam Suk, Lee, Seok Cheol, Oh, Su Jin, Jang, Seok Hoon, Kim, In Hoo, Kim, Dae Yong, Kim, Hark Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022828/
https://www.ncbi.nlm.nih.gov/pubmed/24851111
http://dx.doi.org/10.4143/crt.2014.46.2.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022828/
https://www.ncbi.nlm.nih.gov/pubmed/24851111
http://dx.doi.org/10.4143/crt.2014.46.2.186

Ejemplares similares